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Our hypothesis is that allosteric receptor-receptor interactions in homo- and heteroreceptor complexes may form the molecular
basis of learning and memory. This principle is illustrated by showing how cocaine abuse can alter the adenosine A2AR-dopamine
D2R heterocomplexes and their receptor-receptor interactions and hereby induce neural plasticity in the basal ganglia. Studies
with A2AR ligands using cocaine self-administration procedures indicate that antagonistic allosteric A2AR-D2R heterocomplexes
of the ventral striatopallidal GABA antireward pathway play a significant role in reducing cocaine induced reward, motivation, and
cocaine seeking. Anticocaine actions of A2AR agonists can also be produced at A2AR homocomplexes in these antireward neurons,
actions in which are independent of D2R signaling. At the A2AR-D2R heterocomplex, they are dependent on the strength of the
antagonistic allosteric A2AR-D2R interaction and the number of A2AR-D2R and A2AR-D2R-sigma1R heterocomplexes present
in the ventral striatopallidal GABA neurons. It involves a differential cocaine-induced increase in sigma1Rs in the ventral versus
the dorsal striatum. In contrast, the allosteric brake on the D2R protomer signaling in the A2AR-D2R heterocomplex of the dorsal
striatopallidal GABA neurons is lost upon cocaine self-administration. This is potentially due to differences in composition and
allosteric plasticity of these complexes versus those in the ventral striatopallidal neurons.
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1. Introduction
The receptor-receptor interaction field began with the studies
on neuropeptide-monoamine receptor-receptor interactions
in brain membrane preparations which altered especially the
affinity of the monoamine receptor subtypes [1, 2]. The aim
of the study was to understand the integration of peptide
and monoamine signals present in many neuronal networks
of the Central Nervous System (CNS). It was proposed that
they took place in postulated heteroreceptor complexes in the
plasma membrane [3]. In these complexes, adaptor proteins
can participate and higher-order homo- and heteroreceptor
complexes can also exist in which allosteric receptor-receptor
interactions operate [4–8]. We call them hetero- or homore-
ceptor complexes since a number of other proteins also par-
ticipate like adaptor proteins which can directly bind to the
receptor protomers undergoing homomerization or het-
eromerization [8–13].
These integrative mechanisms give sophisticated dynam-
ics to the structure and function of the heteroreceptor com-
plexes with regard to alterations of recognition, signaling,
and trafficking of the receptor protomers. Due to allosteric
receptor-receptor interactions, increased diversity and selec-
tivity develop in receptor pharmacology and function [19,
20]. Dynamics is also given to the heteroreceptor complex
through its balance with the corresponding homoreceptor
complexes and other types of heteroreceptor complexes
which share one or more receptor protomers [8, 10, 11].
It is of high interest to understand the role of the allosteric
receptor-receptor interactions in heteroreceptor complexes
in neurons, brain circuits, and at the global network level. In
the current paper, we will discuss how this novel biological
principle can serve to modulate the plasticity and function of
the neural-glial networks of the CNS. The major focus will
be on how cocaine abuse in rats can alter the adenosine A2A
receptor- (A2AR-) dopamine D2 receptor (D2R) heterocom-
plexes and their receptor-receptor interactions in the neural-
glial networks of the basal ganglia [12, 21].
2. Integration of Volume Transmission and
Synaptic Transmission in the Neural-Glial
Networks of the CNS through
Receptor-Receptor Interactions in
Heteroreceptor Complexes
TheGprotein-coupled receptor (GPCR) heterocomplex con-
cept includes not only GPCR-GPCR heterocomplexes but
also the interactions between GPCR and other membrane
receptors, for instance, the ion channel receptors or receptor
tyrosine kinases (RTK) heterocomplexes [9, 22–29]. GPCRs
with high affinity for neurotransmitters are major receptors
for volume transmission (VT) and ion channel receptors like
NMDA, AMPA, and GABA receptors are major receptors
for synaptic transmission. Therefore, GPCR-ion channel
receptor heterocomplexes are major integrators of VT and
synaptic transmission in neural-glial networks [30, 31]. This
integration, which takes place at both the prejunctional
and postjunctional level, can up- or downregulate synaptic
efficacy and thus synaptic strength within neural-glial net-
works.The VT signals may originate, for example, from local
glial cells, extrasynaptic release of transmitters from neural
afferents, local collaterals, and soma-dendrites and from dif-
fusion and flow of for example, neuropeptides, and proteins
or of extracellular vesicles from cerebrospinal fluids and/or
surrounding neural-glial networks also forming functional
modules.This major mechanism for the balance and integra-
tion of synaptic and volume transmission may then lead to
changes in the preferred outputs from the neural-glial mod-
ule which in turn will change the function in the brain circuit
involved.
Instead, GPCR-RTK heterocomplexes are of relevance
for the survival and repair of the neural-glial networks by
integrating and balancing trophic signaling with the GPCR-
mediatedmetabolic signaling and information handling [32].
Relevant examples of direct GPCR-RTK receptor-receptor
interactions are A2AR-FGFR1 [25, 33], 5-HT1A-FGFR1 [9, 27,
28], M3R-FGFR1 [34], TGR5-EGFR [35], and ADRB2-INR
heteroreceptor complexes [36]. Wiese et al. [37] and Assaife-
Lopes et al. [38] demonstrated transactivation mechanisms
between adenosine A2A receptor and TrkB receptor, which
can involve allosteric mechanisms via direct GPCR-RTK
interactions.
The changes in the protomer signaling panorama within
the heteroreceptor complexmay be highly dynamic processes
related to the transient nature of the receptor complexes
formed and can represent learning if by repetition it leads to
short-term memory (see below) [13, 31].
3. Understanding the Molecular Basis of
Learning and Memory through Allosteric
Receptor-Receptor Interactions in Multiple
Homo- and Heteroreceptor Complexes in
Neuronal Networks
Changes in synaptic efficacies via alterations in synaptic
strength are regarded as fundamental to learning [39]. The
theory was recently advanced that such changes in synaptic
plasticity can be brought about by anatomical reorgani-
zation of multiple postsynaptic homo- and heteroreceptor
complexes and by resetting the multiple allosteric receptor-
receptor interactions according to the patterns and amounts
of synaptic signals released from the synaptic terminals
decoded from the arriving patterns of action potentials [13,
31]. Such a molecular reorganization of the receptor-protein
architecture of the entire postsynapticmembrane is proposed
to be themolecular basis of learning and short-termmemory.
It may be described as a change of the barcode in the
individual synapse, which leads to the formation of a new
molecular engram. According to the theory, a reorganization
of presynaptic homo- and heteroreceptor complexes also
developed in the learning and memory process in order
to ensure the maintenance of the pattern and amounts of
multiple transmitters andmodulators released whichmust be
sensed by the postsynaptic membrane (Figure 1).
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Figure 1: Illustration of possible reorganization of the homo- and heteroreceptor complexes within the synaptic and extrasynaptic regions
of the glutamate synapses of the striatopallidal GABA neurons in the learning process. The receptor monomers are not illustrated. The left
panel represents the basal state and the right panel the state that has developed in the learning process.They can become stabilized into a long
lasting receptor assemblies through the formation of novel adaptor and scaffolding proteins. If so, they will represent short-term memory
that can be converted into long-term memory through further consolidation.
Previous work discussed howGPCRmodulates the kinet-
ics of G protein signaling [40]. The signaling dynamics of 5-
HT1A-FGFR1 and D2-NTS1 heteroreceptor complexes were
also reported [26, 41]. Oligomer size of diffusing GPCRs in
the plasma membrane can be determined by fluorescence
correlation spectroscopy with photon counting histogram
analysis and the 5-HT2C receptor diffused as a dimer [42].
Single fluorescent-molecule imaging demonstrates dynamic
GPCR dimerization using a chemoattractant GPCR, the N-
fomyl peptide receptor (FPR) [43]. A number of cycles of
monomer and homodimer formation take place over one
second. Thus, FPR dimers are quickly formed from FPR
monomers and FPR monomers are rapidly formed from
rapid dissociation of the FPR dimers [44]. Experimental
studies support the view that the dynamic properties of
GPCRs depend on their coupling to the membrane environ-
ment, where the lipid composition plays a role in ligand-
induced properties [45]. The dynamics are also indicated
from studies using spatial intensity distribution analysis [46]
and RT-BRET to understand the oligomeric organization of
GPCRs [26]. The analysis demonstrated multiple forms from
monomers to higher-order oligomers of the GPCR studied.
These studies support our view that the dynamic
panorama of homo- and heteroreceptor complexes and their
stabilization can form the basis of learning andmemory at the
molecular level and represent the molecular engram, when
consolidated (Figure 1).
Our hypothesis on the molecular basis of learning and
memory is summarized as follows:
(i) Learning requires a new temporal qualitative and
quantitative pattern of release of neurotransmitters.
The transient reorganization of the homo- and het-
eroreceptor complexes in the postsynaptic membrane
contributes to pattern formation.
(ii) This molecular reorganization of the postsynaptic
membrane leads to a novel barcode, which represents
a short-term memory (transient molecular engram)
and defines the new pattern of transmitter release.
(iii) This memory process is facilitated by the reorgani-
zation also of the presynaptic receptor complexes to
help maintain the new transmitter release pattern to
be learned by the postsynaptic membrane. Thus, the
altered transmitter panorama can change the forma-
tion or disrupt the presynaptic receptor complexes
through agonist dependent processes. A retrograde
feedback from the new postsynaptic transient molec-
ular engram can also assist in this process. It can
involve the release and diffusion of soluble factors
like purines and trophic factors and of extracellular
vesicles like exosomes and microvesicles containing
proteins including receptors and lipids.
(iv) The consolidated reorganization of the postsynaptic
receptor complexes and their extrasynaptic regions,
including changes in scaffold proteins like Disc1
and SHANK, can lead to long-term memory. The
long-term memory should result in a barcode and
molecular engram similar to one found in short-term
memory.Themechanism for this processmay involve
the transformation of parts of the heteroreceptor
complexes into unique transcription factors which
can lead to the formation of novel adaptor proteins
like GPCR interacting proteins and receptor activity-
modifying proteins. Some of these proteins can link
the heteroreceptor complexes more strongly together.
Others can link the heteroreceptor complexes more
strongly to the cytoskeleton and to scaffold proteins
and synaptic cell adhesion molecules.
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(v) Of special interest for the formation of truly long-
term molecular engrams may be the release of trans-
mitters from close-by terminals belonging to emo-
tional brain circuits using, for example, dopamine
(DA) as a transmitter [31]. When such terminal
networks are activated due to motivation and reward
linked to the learning andmemory process, the trans-
mitter, for example, DA, can interact with the synapse,
where themolecular engram is being formed, through
short distance volume transmission. It is postulated
that the activation of, for example, synaptic and
extrasynaptic DA heteroreceptor complexes on the
postsynaptic side has an ability via unique transcrip-
tion factors to produce special adaptor proteins that
can bind to the receptor-protein architecture of the
molecular engram and consolidate them with an
exceptional efficacy leading to life-long memories.
4. On the Role of Antagonistic A2A-D2
Allosteric Receptor-Receptor Interactions
in Heteroreceptor Complexes for
Neuronal Plasticity: Studies in Cocaine Use
Disorder Models
It was early on observed that the adenosine A2AR agonist
CGS 21680 reduced the affinity of the dopamine D2R agonist
binding sites, especially in the high affinity state, in dorsal
striatum and nucleus accumbens [47, 48]. Thus, antagonistic
A2AR-D2R interactions appear to exist in the plasma mem-
brane of neurons. It was further demonstrated that theA2ARs
and D2Rs coaggregate, cointernalize, and codesensitize in
heteroreceptor complexes [49]. In line with these findings,
agonist activation of the A2AR protomer in the A2AR-
D2R heteroreceptor complexes reduces D2R Gi/o-mediated
signaling through the allosteric receptor-receptor interaction
[19, 50]. Instead, the A2AR agonist increases the D2R beta-
arrestin2 mediated signaling and can be characterized as a
biased inhibitory modulator of the Gi/o-mediated D2R sig-
naling [51]. This action may explain its atypical antipsychotic
activities [50, 52].
The A2AR-D2R heterocomplexes interface involves
mainly intracellular domains where electrostatic interactions
form clasps in the interface (hot spots) [53–55] and
transmembrane domains [56] where triplet amino acid
homologies can play a special role as adhesive guides in the
formation of the heteromer [57].
The overall architecture of the global GPCR heterodimer
network (http://www.gpcr-hetnet.com/) [58] demonstrates
that both A2ARs and D2Rs are hub components, each able
to interact with ten or more different GPCRs. Thus, the
A2AR-D2R heteroreceptor complex in a neuron can be in a
complex balance not only withA2AR andD2Rhomoreceptor
complexes but also with other types of A2AR and D2R
heteroreceptor complexes, respectively [8, 10, 11].
The A2AR-DR2 heteroreceptor complexes were demon-
strated in the dorsal and ventral striatum by means of the
proximity ligation assay (in situ PLA) [34, 59]. In relation
to cocaine use disorder, it is of substantial interest that these
complexes may participate in postjunctional mesolimbic DA
transmission in the nucleus accumbens core and shell in view
of their presence in high densities in these two regions.
In situ PLA-positive A2AR-D2R heteroreceptor com-
plexes are visualized in striatal sections as red clusters (blobs,
puncta) within different regions of the neuropil of caudate
putamen and nucleus accumbens core and shell, which can
be quantitated as, for example, average number of blobs/cell
[34].
4.1. Ventral Striatopallidal GABA Neurons. A2AR-D2R het-
eroreceptor complexes exist mainly in the ventral striatopal-
lidal GABA neurons that mediate antireward [60]. The
circuit continues from the ventral pallidum into the medial
thalamic nucleus-prefrontal cortex as well as into the ventral
midbrain, there mainly appearing as collaterals from the
other regions [61]. The stoichiometry of these complexes
is unknown but can involve heterotrimers, heterotetramers,
and etcetera. Also the critical balance with other types of
A2AR or D2R heteroreceptor complexes is unknown [11].
One ventral striatopallidal GABA neuron may differ from
another one with regard to the stoichiometry and composi-
tion of the A2AR-D2R heteroreceptor complexes as well as
their distribution pattern among synapses. Does each neuron
of this pathway possess a unique distribution of A2AR-D2R
heteroreceptor complexes to certain of its synapses while
others lack these complexes? Can the switching in the balance
between different D2R and A2AR heteroreceptor complexes
in the same synapse be part of the learning process and
contribute to short term and, if relevant, long-term memory
and thus to the formation of amolecular engram (see above)?
It is also of special interest that a loss of TrkB, the receptor for
BDNF, inD2Rpositive accumbens neurons leads to increased
neuronal excitability and suppression of reward [60]. These
results open up the possibility that TrkB-D2R heteroreceptor
complexes exist in which TrkB directly or indirectly make
the inhibitory Gi/o-mediated D2R signaling possible, which
leads to hyperpolarization and reduced excitability and firing.
Thus, it appears possible that A2AR-D2R-TrkB heterorecep-
tor complexes can also exist in this antireward system. In
fact, it was found that A2ARs are necessary for the baseline
BDNF levels and for enhancement of synaptic transmission
by BDNF as determined in the hippocampus [62].
4.2. Pharmacological Studies with Cocaine Self-Administration
Procedures. We have studied the effects of the A2AR agonist
CGS 21680 on cocaine self-administration under different
schedules of reinforcement. Active lever presses and cocaine
infusions were attenuated by CGS 21680 [63] and these
effects could not be explained by sedation and reduction
in locomotion although such inhibitory motor actions are
linked toA2AR activation [63].These results clearly indicated
that activation of A2ARs inhibits cocaine-induced reward in
agreement with previous work [21, 64]. Of substantial interest
were the inhibitory effects of the CGS 21680 treatment
in a progressive ratio schedule of reinforcement protocol
with a 4-hour breaking point [63] indicating that A2AR
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stimulation brings down not only cocaine reward but also
cocaine motivation.
A neurochemical correlate was also obtained. The effects
of an accumbal perfusion of CGS 21680 were studied on
changes induced by a 2 h cocaine self-administration session
on extracellular accumbal DA, GABA, and glutamate levels.
In the cocaine self-administration session over 2 h, CGS
21680 induced an increase in extracellularGABA levels which
appeared to reduce the increase in extracellular DA levels
found during cocaine self-administration [63]. This mecha-
nismmay restore the glutamate drive to the prefrontal cortex
from the dorsomedial thalamic nucleus [50] helping the pre-
frontal cortex to restore its control of the accumbens reward
system. These results are compatible with the involvement of
antagonistic allosteric A2AR-D2R interactions in the ventral
striatopallidal antireward system in mediating the A2AR
induced inhibition of cocaine reward [63]. Thus, restoring
the allosteric antagonistic plasticity in the neuronal A2AR-
D2R heteroreceptor complex may contribute to anticocaine
actions of A2AR agonists.
Such an increase in antagonistic allosteric plasticity
in the A2AR-D2R heteroreceptor complex can also help
explain why the A2AR agonist CGS 21680 produced a dose-
dependent blockade of the cocaine, quinpirole, and cue-
induced reinstatement of cocaine seeking [65, 66]. In support
of the view that the antagonistic A2AR-D2R interactionsmay
control drug seeking, it was found that CGS 21680was 4 times
more powerful in counteracting the D2-like receptor agonist
quinpirole-induced relapse versus cocaine-induced relapse.
These inhibitory actions of CGS 21680 towards cocaine-
or quinpirole-induced reinstatement of cocaine seeking
behaviors in rats were in line with previous studies using
i.p. injections or intra-accumbal infusions with the A2AR
agonist [67]. CGS 21680 also blocked cue-induced food
seeking [65]. It is of relevance to point out that there exist
also targets in the nucleus accumbens for A2AR agonists
other than the A2AR-D2R heteroreceptor complexes like
the A1-A2A heteroreceptor complexes preferentially located
on the corticostriatal glutamate terminals [68, 69]. Here,
A2AR agonists can enhance glutamate release inter alia by
an antagonistic allosteric receptor-receptor interaction with
the A1R protomer which reduces its brake on glutamate
release, which can modulate the activity of the D2R positive
antireward and D1R positive reward neurons. Furthermore,
there is evidence for the existence of postjunctional A2AR-
mGlu5R and A2AR-D2R-mGlu5R heteroreceptor complexes
in the striatopallidal GABA neurons [69, 70] where the
mGlu5R protomer synergizes with the A2AR protomer to
reduce D2R protomer signaling and its inhibition of the
striatopallidal GABA neurons [71]. By targeting also these
heterocomplexes, the anticocaine actions of A2AR agonists
can become amplified.
It is also possible that these two types of A2AR-mGlu5R
heteroreceptor complexes exist in the glutamate nerve termi-
nals where the A2ARs andmGlu5Rs colocalize and function-
ally interact in synergistically enhancing glutamate release
[72]. It appears that A2AR agonists by targeting several
A2AR heteroreceptor complexes and A2AR homoreceptor
complexes in the nucleus accumbens can increase activity in
the antirewardGABAneurons leading to anticocaine actions.
It was proposed that A2AR participates in a mechanism to
integrate the GABA, DA, and glutamate signaling [73]. In this
mechanism, also A2AR homoreceptor complexes participate
and can inter alia be involved at the presynaptic level in
increasing the synaptic striatopallidal GABA transmission in
the globus pallidus [74].
Underlining the existence of an endogenous adeno-
sine tone reducing D2R signaling, A2AR antagonists KW
6002 and SCH 58261 induce reinstatement of cocaine
seeking behavior in rats extinguished from cocaine self-
administration. The mechanism is proposed to involve a
blockade of the A2AR protomer of the neuronal A2AR-
D2R heteroreceptor complex in the ventral striatopallidal
GABA pathway. By altering the allosteric interactions in
this A2AR-D2R heteroreceptor complex, the brake on D2R
signaling is reduced and cocaine seeking can develop due
to reduction of the glutamate drive to the prefrontal cortex
[50]. In this way, it is possible that cognitive control including
flexible goal-directed behavior probably becomes diminished
and cocaine seeking develops. D2Rs are known to have a
key role in cocaine use disorder [75, 76]. However, A2ARs
appear to have a different role in the dorsal striatum where a
striatum-specific A2AR deletion led to selective impairment
of habit formation [77]. Later on, it was demonstrated that
dorsomedial striatopallidal GABAneurons upon optogenetic
activation of their A2ARs diminished goal-directed behavior
[78]. Thus, in this circuit, A2AR signaling when linked to
reward may favour habit formation.
It is clear, however, that A2AR agonists target both
A2AR homo- and A2AR-D2R heteroreceptor complexes and
that A2AR homoreceptor complexes can contribute to the
anticocaine actions observed. There are at the moment no
preferential A2AR agonists for the A2AR protomer of the
A2AR-D2R heteroreceptor complex nor preferential antago-
nists for the D2R protomer of this complex. Multitargeting
drugs with A2AR agonist [79] and D2R antagonist activities
are promising molecules to combat cocaine use disorder.
Heterobivalent drugs are attractive novel drugs to be
developed [80–83]. In this case, they should be built based
on an A2AR agonist pharmacophore linked to a D2R
antagonist pharmacophorewhich should preferentially target
A2AR-D2R heteroreceptor complexes with a high affinity
and selectivity. Their selective action on neurons containing
A2AR-D2R heteroreceptor complexes may predict less side
effects. Previously, A2AR antagonist-D2R agonist bivalent
compounds were proposed as tools to find A2AR-D2R
receptor heteromers and as a novel strategy for treatment of
Parkinson’s disease [84].
Small inhibitory interface peptides targeting the A2AR-
D2R interface are also of interest as they may block the for-
mation of the A2AR-D2R heteroreceptor complex or alter the
heteroreceptor-mediated signaling [56]. Inhibitory interface
peptides were first used in studies on D5R-GABA-A [23],
D1R-NMDAR [22], and D2R-NR2B [24] heterocomplexes
showing their physiological role. Competitive peptides were
also used in determining the physiological role of A2AR-D2R
heterodimerization in regulating NMDAR mediated excita-
tion of neurons in the nucleus accumbens [85]. Furthermore,
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their use could help to unravel the role of the A2AR-D2R
heteroreceptor complexes versus the A2AR homoreceptor
complex in the actions of A2AR agonists on cocaine reward
and cocaine seeking.
4.3. Allosteric A2AR-D2R Interactions in Cocaine Self-
Administration. Previouswork demonstrated that antagonis-
tic allosteric A2AR-D2R interactions exist in the ventral and
dorsal striatum of drug na¨ıve control rats involving an A2AR
induced reduction of the affinity of the high affinity D2R
agonist binding site [47, 48]. It was therefore of high interest
to study how maintenance of cocaine-self-administration
affected this allosteric interaction in the ventral and dorsal
striatum [16]. It was found that cocaine self-administration
differentially affected the allosteric A2AR-D2R interactions
in the ventral and dorsal striatum versus the yoked saline
group.
The current protocol produces elevation of extracellular
levels of DA in the nucleus accumbens in 2 h cocaine self-
administration sessions [86] and no changes in theA2AR and
D2R antagonist binding sites in the striatumwere observed in
terms of 𝐵max and𝐾𝑑 values [87].
It was found that CGS 21680, the A2AR agonist, ex
vivo using 3H-raclopride/quinpirole competition curves pro-
duced a significant reduction of the affinity of the D2-
like high affinity receptor agonist binding site after cocaine
self-administration in the ventral striatum versus the yoked
saline group.The mechanismmay involve a cocaine-induced
change in the balance of A2AR-D2R heteroreceptor com-
plexes versusA2ARhomoreceptor complexes and other types
of A2AR heteroreceptor complexes favouring an increase in
A2AR-D2R heteroreceptor complexes. Such a change can
contribute to the increase in the antagonistic allosteric A2AR-
D2R interaction observed.
Our hypothesis is that changes in neuronal plastic-
ity in cocaine self-administration may involve a reor-
ganization of the balance of the A2AR monomers and
homo/heteroreceptor complexes which can vary from one
synapse to another and from one neuron to the other
one. Several A2AR heteroreceptor complexes were already
discussed and can be present at the pre- and/or postsynaptic
level including the A2AR-D2R heteroreceptor complexes
and together with other heteroreceptor complexes like the
NMDAR heteroreceptor complexes [22, 24]. It should be
noted that inactivation of A2ARs blocks long-term potenti-
ation [88] and working memory deficits are reversed upon
inactivation of A2ARs [89]. A2ARs can also form heterocom-
plexes with FGFR1 [25, 33].
Another mechanism may be that cocaine through its
release of DA and/or indirect/direct allosteric enhancement
of D2R signaling [90] can induce an allosteric feedback to
help reduce D2R function via this antagonistic allosteric
mechanism in the ventral striatum [16].Thus, the anticocaine
actions of A2AR agonists may at least in part be determined
by the strength of the antagonistic allosteric A2AR-D2R
interaction and the number of A2AR-D2R heteroreceptor
complexes present, which leads to increased activity of
the ventral striatopallidal GABA neurons representing an
antireward system.
Dynamic changes also developed in the allosteric A2AR-
D2R interactions in the dorsal striatum upon maintenance
of cocaine self-administration. However, in this case, they
resulted in disappearance of the antagonistic A2AR-D2R
interaction found in yoked saline rats after ex vivo incubation
of the membrane preparations with the A2AR agonist CGS
21680 [16]. As a consequence, no reduction of the affinity in
theD2R high affinity agonist binding site was observed.Thus,
the allosteric brake on the D2R protomer signaling in the
A2AR-D2R heteroreceptor complex of the dorsal striatopall-
idal GABA neurons is lost upon cocaine self-administration.
This is potentially due to differences in composition and
allosteric plasticity of these complexes versus those in the
ventral striatopallidal neurons. In line with these results,
it was previously found that DA increased its potency to
increase D2R Gi/o coupling in dorsal but not ventral striatal
membranes in cocaine self-administration [87]. It is proposed
that the disappearance of the allosteric brake on the D2R
protomer signaling in the A2AR-D2R heteroreceptor com-
plex can alter cocaine seeking, habit forming learning, and/or
locomotor sensitization which remains to be determined.
In view of the allosteric theory of learning and memory
based on the formation of a molecular engram built up of
homo- and heteroreceptor complexes [12, 13], it is proposed
that the loss of the allostericA2AR-D2R interactions is caused
by a reorganization or loss of the A2AR-D2R heteroreceptor
complex. This leads to an alteration of the molecular engram
in the synapses affected linked to a change in learning
due to loss of the allosteric brake. The altered long-term
memories formed are likely the basis for the novel habits
formed versus goal-directed behavior. Neuronal plasticity
induced by cocaine at the molecular level through allosteric
mechanisms can therefore produce changes in the brain
circuits involved. According to the work of Li et al. [78],
increases in A2AR signaling should lead to suppression of
goal-directed behavior. Therefore, the increased balance of
A2AR and D2R signaling in the dorsomedial striatopallidal
GABA neurons through loss of the inhibitory allosteric
mechanism should reduce, if anything, the appearance of
abnormal habit formation.
The hypothesis is advanced that the mechanism for the
potential therapeutic actions of A2AR agonists in cocaine
addiction is their ability to activate the A2AR brake on
D2R protomer signaling in the ventral striatum even more
strongly in this disease than in drug na¨ıve controls. This
action will markedly reduce the rewarding actions of cocaine
through the activation of the antireward system. However,
the A2AR protomer brake on the D2R protomer signaling
in the dorsal striatum in contrast disappears upon prolonged
cocaine use. Its impact on cocaine seeking behavior remains
to be determined.
Themechanism for the differential effects observed on the
allosteric A2AR-D2R interactions in the ventral versus the
dorsal striatum in cocaine self-administration can depend on
regional differences in the stoichiometry and composition of
the A2AR-D2R heteroreceptor complexes [10, 11]. This could
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involve differential recruitment of adaptor proteins and other
receptors to the heteroreceptor complex.
5. On the Existence of Sigma-1R-D2R and
A2AR-D2R-Sigma-1R Heteroreceptor
Complexes in the Ventral and Dorsal
Striatum and Their Potential to
Understand the Differential Allosteric
A2AR-D2R Receptor-Receptor Interactions
in These Regions
It is known that sigma-1R-D2R heteroreceptor complexes
exist and form higher-order oligomers and are specific for
D2Rs versus D3Rs and D4Rs [17]. Recently, it was shown
with BRET analysis that sigma-1Rs form heteroreceptor
complexes to the samedegreewithD2 short and long receptor
isoforms [14, 15]. It is of substantial interest that the sigma-
1R addition in increasing concentrations does not reduce
the BRET signal obtained with either D2 short or D2 long
isoforms in cell models. The explanation can be multiple
interfaces for sigma-1R-D2R interactions; that is, the sigma-
1R may bind to different regions of the D2R [15]. With
in situ PLA, the sigma-1R-D2R heteroreceptor complexes
were demonstrated within discrete regions of the dorsal and
ventral striatum of the rat [14, 15]. The densities of complexes
were substantially higher in the dorsal versus the ventral
striatum [14, 15] and a selective cocaine-induced increase
of the sigma1Rs was demonstrated in the ventral versus
the dorsal striatum [18]. These results can help understand
the differential effects on allosteric A2AR-D2R interactions
observed upon cocaine self-administration in the ventral and
dorsal striatum (see above). The mechanism may involve an
increased presence of A2AR-D2R-sigma-1R heteroreceptor
complexes in the ventral versus the dorsal striatum after
cocaine self-administration (Figure 2).
In relation to this hypothesis, there are novel data on the
actions of cocaine at a low concentration on D2R signaling
using CREB luciferase reporter gene assay in HEK293 cells.
Cocaine (100 nM) increased the potency of D2R signaling
when D2Rs and sigma-1Rs were expressed together [14].
Cocaine lacked effects when the D2Rs were expressed alone.
Thus, cocaine at a low concentration can enhance the D2R
mediated neurochemical effects like enhancement of Gi/o-
mediated coupling but only in the sigma-1R-D2R heterore-
ceptor complex. These effects remained in the presence of
DA transporter inhibitors and likely represented allosteric
effects on the D2R protomers mediated via the sigma-1R
in the heteroreceptor complex. In the absence of cocaine, a
coexpression of D2Rs and sigma-1Rs show a reduced potency
of D2R agonists to inhibit the CREB signal [14, 15]. It is of
high interest that, even in the presence of 100 nM cocaine,
CGS 21680 strongly reduced the potency of the D2R agonist
to inhibit the CREB signal. This suggests the existence of
a putative A2AR-D2R-sigma-1R heteroreceptor complex in
HEK293 cells where the antagonistic A2AR-D2R interactions
may be strongly enhanced. In this context, it is relevant to
notice the partial overlap in the distribution of D2R-sigma1R
and A2AR-D2R heteroreceptor complexes in the nucleus
accumbens shell as found with in situ PLA [15].
In line with these results, it was found in HEK293
cells coexpressing sigma-1Rs and D2Rs that cocaine at 1 nM
increased the 𝐵max values of plasma membrane D2Rs, an
action blocked by the sigma-1R antagonist PD 144418. The
mechanism for the increase in the 𝐵max values can involve a
blockade of cocaine-induced D2R-YFP internalization when
the sigma-1R forms a heteroreceptor complex with the D2R.
This action was so far observed in the 1–100 nM range of
cocaine [14, 15]. These results on cocaine actions in the
nanomolar range on D2R-sigma-1R and on putative A2AR-
D2R-sigma-1R heteroreceptor complexes are of high interest.
They offer a new possibility to understand the differential
effects of self-administered cocaine on the allosteric A2AR-
D2R interactions in the dorsal versus the ventral striatum in
the cocaine self-administration experiments (Figure 2).
It is proposed that the higher density of D2R/sigma-1R
heterocomplexes in the dorsal versus the ventral striatum
[14, 15] and selective cocaine-induced increases of the sigma-
1Rs in the ventral striatum [18] contribute to the differen-
tial effects of self-administered cocaine on the A2AR-D2R
interactions in the dorsal and ventral striatum, respectively
(Figure 2).The sigma-1R is amolecular chaperonewhich inter
alia assists in the translocation of receptors, especially D2Rs,
to the plasma membrane through its binding to the receptor.
It can also directly bind to the D2R in the plasma membrane
[17, 91].
6. Conclusions
The current overview supports the hypothesis that the A2AR
agonists represent novel drugs against cocaine use disorder
because they inter alia can trigger the antagonistic allosteric
A2AR-D2R interactions in A2AR-DR2 and A2AR-D2R-
sigma-1R heteroreceptor complexes located in the ventral
striatum. However, also A2AR homoreceptor complexes can
participate as well as other types of A2AR heteroreceptor
complexes like A2AR-mGlu5R and A2AR-mGlu5R-D2R het-
eroreceptor complexes [73, 92]. Such actions would result
in increased activity in the ventral striatopallidal GABA
antireward pathway thus leading to reward reversal and
reduction of cocaine reinforcement in self-administration.
The mechanism may in cocaine self-administration involve
a differential reorganization of the A2AR-D2R, sigma-1R-
D2R, and A2AR-D2R-sigma-1R heteroreceptor complexes
and their balance with A2AR homoreceptor complexes and
other types of A2AR heteroreceptor complexes in the ventral
striatum as discussed above. It can lead to the differential
dopaminergic signaling observed in the ventral and dorsal
striatum with selective A2AR agonist induced inhibition of
D2R signaling in the ventral striatum (Figure 2). The loss
of the antagonistic allosteric A2AR-D2R interactions in the
dorsal striatopallidal GABA neurons of the dorsal striatum
found in cocaine self-stimulation can have an impact onnovel
habit formation versus goal-directed behavior that remains to
be determined [78].
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Disappearance of the antagonistic allosteric receptor-receptor interactions
Dorsal striatum
Cocaine self-administrationYoked-saline
Cocaine
ER σ1R σ1R memb.
D2R-𝜎1R A2AR-D2R-𝜎1R A2AR-D2R D2R-𝜎1R D2R-D2R
⊖⊖
↓↓ ↑↑↑↑ ↑
(a)
Appearance of the antagonistic allosteric receptor-receptor interactions
Ventral striatum
Cocaine self-administrationYoked-saline
D2R-𝜎1R A2AR-D2R-𝜎1R
Cocaine
ER σ1R σ1R memb.
A2AR-D2R-𝜎1R
⊖ ⊖ ⊖
↓↓
↑↑↑
↑↑
(b)
Figure 2: ((a) Dorsal striatum) Yoked saline group. The high density of D2R-sigma1R [14, 15] leads to an increased formation of A2AR-D2R-
sigma1R heterocomplexes which together with the A2AR-D2R heterocomplexes can be in dominance over D2 homoreceptor complexes.This
can help explain the significant antagonistic A2AR-D2R interaction observed [16]. Cocaine self-administration (maintenance) group. Cocaine
can bind to the sigma1R [17] but does not increase its recruitment to the plasma membrane in the dorsal striatum [18]. Instead, it is proposed
that the major change induced by cocaine can be the increase in extracellular DA levels which is postulated to increase the formation of D2R
homoreceptor complexes. Due to competition, this can reduce the number of A2AR-D2R andA2AR-D2R-sigma1R heteroreceptor complexes.
As a result, the antagonistic allosteric A2AR-D2R interactions disappear [16]. ((b) Ventral striatum) Yoked saline group.The lower density of
D2R-sigma-1R, especially in nuc accumbens core [14, 15], may lead to the preferential formation of D2R-sigma1R heterocomplexes in view
of a possible higher affinity of sigma1R for D2R monomer-homoreceptor complexes versus the affinity for the A2AR-D2R heteroreceptor
complexes. Due to competition, the A2AR-D2R heteroreceptor complexes will become reduced and only weak nonsignificant antagonistic
A2AR-D2R interactions develop. Cocaine self-administration (maintenance) group. Upon cocaine self-administration, cocaine can here
increase sigma1R expression [18] and increase its recruitment to the plasma membrane where it interacts with D2R potentially at several
interfaces. In view of the marked increase of sigma1R in the plasma membrane increased formation of A2AR-D2R-sigma1R heteroreceptor
complexes can develop with restoration of significant antagonistic A2AR-D2R interactions [16] in spite of increases in extracellular DA levels
postulated to favour D2R homodimerization.
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